Authors:
Harris, CL
Vigar, MA
Nores, JER
Horejsi, V
Labeta, MO
Morgan, BP
Citation: Cl. Harris et al., The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa, IMMUNOLOGY, 104(3), 2001, pp. 317-323
Authors:
Miwa, T
Sun, XJ
Ohta, R
Okada, N
Harris, CL
Morgan, BP
Song, WC
Citation: T. Miwa et al., Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity, IMMUNOLOGY, 104(2), 2001, pp. 207-214
Authors:
Holt, DS
Botto, M
Bygrave, AE
Hanna, SM
Walport, MJ
Morgan, BP
Citation: Ds. Holt et al., Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria, BLOOD, 98(2), 2001, pp. 442-449
Authors:
Mizuno, M
Nishikawa, K
Spiller, OB
Morgan, BP
Okada, N
Okada, H
Matsuo, S
Citation: M. Mizuno et al., Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats, ARTH RHEUM, 44(10), 2001, pp. 2425-2434
Authors:
Lukasser-Vogl, E
Gruber, A
Lass-Florl, C
Eder, A
Hogasen, AKM
Morgan, BP
Dierich, MP
Wurzner, R
Citation: E. Lukasser-vogl et al., Membrane attack complex formation on yeast as trigger of selective releaseof terminal complement proteins from human polymorphonuclear leukocytes, FEMS IM MED, 28(1), 2000, pp. 15-23
Authors:
Watanabe, M
Morita, Y
Mizuno, M
Nishikawa, K
Yuzawa, Y
Hotta, N
Morgan, BP
Okada, N
Okada, H
Matsuo, S
Citation: M. Watanabe et al., CD59 protects rat kidney from complement mediated injury in collaboration with Crry, KIDNEY INT, 58(4), 2000, pp. 1569-1579
Authors:
Fisicaro, N
Aminian, A
Hinchliffe, SJ
Morgan, BP
Pearse, MJ
D'Apice, AJF
Cowan, PJ
Citation: N. Fisicaro et al., The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement, TRANSPLANT, 70(6), 2000, pp. 963-968
Authors:
van den Berg, CW
Rix, C
Hanna, SM
de la Lastra, JMP
Morgan, BP
Citation: Cw. Van Den Berg et al., Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells, TRANSPLANT, 70(4), 2000, pp. 667-673
Authors:
Spiller, OB
Goodfellow, IG
Evans, DJ
Almond, JW
Morgan, BP
Citation: Ob. Spiller et al., Echoviruses and Coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF, J INFEC DIS, 181(1), 2000, pp. 340-343
Authors:
de la Lastra, JMP
Harris, CL
Hinchliffe, SJ
Holt, DS
Rushmere, NK
Morgan, BP
Citation: Jmp. De La Lastra et al., Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats, J IMMUNOL, 165(5), 2000, pp. 2563-2573
Authors:
Labeta, MO
Vidal, K
Nores, JER
Arias, M
Vita, N
Morgan, BP
Guillemot, JC
Loyaux, D
Ferrara, P
Schmid, D
Affolter, M
Borysiewicz, LK
Donnet-Hughes, A
Schiffrin, EJ
Citation: Mo. Labeta et al., Innate recognition of bacteria in human milk is mediated by a milk-derivedhighly expressed pattern recognition receptor, soluble CD14, J EXP MED, 191(10), 2000, pp. 1807-1812
Citation: Nk. Rushmere et al., Production and functional characterization of a soluble recombinant form ofmouse CD59, IMMUNOLOGY, 99(2), 2000, pp. 326-332
Authors:
Quigg, RJ
He, C
Hack, BK
Alexander, JJ
Morgan, BP
Citation: Rj. Quigg et al., Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris, IMMUNOLOGY, 99(1), 2000, pp. 46-53
Citation: Cl. Harris et al., Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities, IMMUNOLOGY, 100(4), 2000, pp. 462-470
Authors:
Spiller, OB
Criado-Garcia, O
De Cordoba, SR
Morgan, BP
Citation: Ob. Spiller et al., Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack, CLIN EXP IM, 121(2), 2000, pp. 234-241
Authors:
Mizuno, M
Nishikawa, K
Morgan, BP
Matsuo, S
Citation: M. Mizuno et al., Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59, CLIN EXP IM, 119(2), 2000, pp. 368-375